Munich, Germany, 21 October 2018 - Neoadjuvant erlotinib benefits selected epidermal growth factor receptor (EGFR)-mutated patients who undergo complete resection...
Oncology trial RTOG 0232 comparing a combined treatment of external beam therapy and brachytherapy (EBT+B) to transperineal interstitial permanent brachytherapy...
Data from a validation study of NRG-RTOG 0521 suggests that, while there is no association between an elevated level of...
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservation surgery but...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A combination of the immune checkpoint blocker,...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Radiotherapy to the prostate improves overall survival...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - Two-year maintenance therapy with olaparib, a PARP...
A new study reveals that Hispanic HIV-infected adults in the United States are at a higher risk of developing cancers...
ESMO 2018 abstract LBA21 - "InterAACT: A multicentre open label randomised phase II advanced anal cancer trial of cisplatin (CDDP)...
Credit: Dong-Ha Bhang, Penn Medicine: Nature Communications PHILADELPHIA - Researchers have discovered a way to grow human stem cells destined...
Biological medicines are responsible for some of the most promising innovations in cancer treatment, including immunotherapy, targeted drugs and vaccines...
Credit: © European Society for Medical Oncology Munich, Germany, 21 October 2018 - A high concentration of multi-strain probiotic helps...
Munich, Germany, 20 October 2018 - Adjuvant treatment with the bone sparing drug zoledronic acid plus hormonal therapy with the...
Credit: © European Society for Medical Oncology Munich, Germany, 20 October 2018 - Epigenetic therapy with histone deacetylase (HDAC) inhibitors...
(European Society for Medical Oncology) Targeting a common mutation in patients with hormone receptor positive (HR+) HER2 negative (HER2-) advanced...
Credit: Duke-NUS Medical School Singapore, 22 October 2018 - Global efforts in immuno-oncology have received a major boost, with a...
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Immunotherapy with nivolumab and low-dose ipilimumab could...
Credit: © European Society for Medical Oncology Munich, Germany, 22 October 2018 - Pre-operative treatment with a combination of the...
PHILADELPHIA - A new program project grant from the National Cancer Institute (NCI) will fund research by the Translational Center...
Credit: FSU College of Medicine TALLAHASSEE, Fla. -- While women have long been warned about the dangers of smoking during...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.